https://www.selleckchem.com/pr....oducts/ll37-human.ht
Our findings also highlight the therapeutic value of inhibiting ALOX5 in breast cancer, particularly those patients with the HER2 overexpression. -Defensin 118 (DEFB118) is a novel host defense peptide (HDP) identified in humans. To evaluate its potentials for future utilization, the DEFB118 gene was expressed in ( ) and the recombinant protein was fully characterized. The DEFB118 protein was obtained by heterologous expression using Rosetta (DE3). Antibacterial activity of DEFB118 was determined by using various bacterial strains. I
Like
Comment
Share
